In this regard, GLP-1R agonists and GLP-1 analogs (exenatide, liraglutide, and lixisenatide), used to treat diabetes, have been identified as promising drugs for PD, showing neuroprotective and neurorestorative properties. The gene discussed is GCG; the disease is Parkinson disease.